Implementation of an enhanced recovery after surgery program with robotic surgery in high-risk patients obtains optimal results after colorectal resections

被引:0
作者
Lidia Cristóbal Poch
Carmen Cagigas Fernández
Marcos Gómez-Ruiz
Marta Ortega Roldán
Ramón Cantero Cid
Julio Castillo Diego
Manuel Gómez-Fleitas
机构
[1] Colorectal Surgery Unit. Hospital Universitario “Marques de Valdecilla”,Surgical Innovation Research Group Valdecilla Biomedical Research Center
[2] IDIVAL,undefined
[3] University of Cantabria,undefined
[4] Colorectal Surgery Unit. Hospital Universitario “La Paz”,undefined
[5] University of Cantabria,undefined
[6] Colorectal Surgery Unit,undefined
[7] Hospital Universitario,undefined
[8] “Marques de Valdecilla”,undefined
来源
Journal of Robotic Surgery | 2022年 / 16卷
关键词
Enhanced recovery after surgery; Colorectal surgery; Laparoscopic; Robotic surgery;
D O I
暂无
中图分类号
学科分类号
摘要
Enhanced recovery after surgery programs reduce postoperative complications and length of stay after laparoscopic colorectal surgery, but are still under evaluation after robotic colorectal surgery. To evaluate potential benefits in terms of length of stay and complications of an Enhanced recovery after surgery program in colorectal surgery. A subanalysis was performed to assess what combination of surgical approach and perioperative care had better outcomes. Prospective observational cohort study. 300 consecutive colorectal surgery patients: 150 were prospectively included in the enhanced recovery after Surgery program group and 150 retrospectively in the traditional care group, and subdivided according to the type of surgery, in Hospital Marques de Valdecilla, between 2013 and 2016. Postoperative complications decreased significantly (p = 0.002) from 46 to 28% (traditional care vs program group). The length of stay was decreased by 2 days (p < 0.001). Multivariate analysis indicated similar effect sizes after adjusting for age, gender, Charlson score, and type of surgery. Type of surgery was an independent predictive factor for postoperative complications and length of stay. Compared to open surgery, postoperative complications decreased by 50% (p < 0.001) after robotic surgery and by 40% (p = 0.01) after laparoscopic surgery, while the median length of stay decreased by three days (p < 0.001) after minimally invasive surgery. Enhanced recovery after surgery program and minimally invasive surgery were associated with decreased morbidity and length of stay after colorectal surgery compared to open surgery and traditional care. An enhanced recovery after surgery program with robotic surgery in high-risk patients might be beneficial.
引用
收藏
页码:575 / 586
页数:11
相关论文
共 148 条
[1]  
Slim K(2011)Fast-track surgery: the next revolution in surgical care following laparoscopy Colorectal Dis 13 478-480
[2]  
Abraham NS(2004)Meta-analysis of short-term outcomes after laparoscopic resection for colorectal cancer Br J Surg 91 1111-1124
[3]  
Young JM(2002)Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial Lancet 359 2224-2229
[4]  
Solomon MJ(2002)Short-term quality-of-life outcomes following laparoscopic-assisted colectomy versus open colectomy for colon cancer: a randomized trial JAMA 287 321-328
[5]  
Lacy AM(2004)Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial Lancet 363 1187-1192
[6]  
García-Valdecasas JC(2007)Laparoscopic colectomy for cancer is not inferior to open surgery base don 5-year data from the cost study Group trial Ann Surg 246 655-662
[7]  
Delgado S(2002)COLOR: a randomized clinical trial comparing laparoscopic and open resection for colon cancer Surg Endosc 16 949-953
[8]  
Weeks JC(2009)A randomized clinical trial comparing laparoscopic and open surgery for rectal cancer Dan Med Bull 56 89-91
[9]  
Nelson H(2007)Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3 year results of the UK MRC CLASICC Trial Group J Clin Oncol 25 3061-3068
[10]  
Gelber S(2015)Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes the ACOSOG Z6051 randomized clinical trial JAMA 314 1346-1355